News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current NAMSW market cap is 750.48M. The company's latest EPS is EUR -2.1455 and P/E is -9.14.
| Quarter End | |
|---|---|
| EUR (€) | |
| Total Revenue | |
| Operating Income | |
| Net Income |
| Year End December 30 2023 | 2023 |
|---|---|
| EUR (€) | |
| Total Revenue | 14.09M |
| Operating Income | -182.69M |
| Net Income | -176.94M |
| Quarter End | |
|---|---|
| EUR (€) | |
| Total Assets | |
| Total Liabilities | |
| Total Equity |
| Year End December 30 2023 | 2023 |
|---|---|
| EUR (€) | |
| Total Assets | 347.1M |
| Total Liabilities | 58.7M |
| Total Equity | 288.39M |
| Market Cap | 750.48M |
| Price to Earnings Ratio | -9.14 |
| Price to Sales Ratio | 114.69 |
| Price to Cash Ratio | 4.75 |
| Price to Book Ratio | 5.6 |
| Dividend Yield | - |
| Shares Outstanding | 82.47M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 1.08 (10.61%) |
| Company Name | NewAmsterdam Pharma Company NV |
| Address |
gooimeer 2-35 naarden, north holland 1411 DC |
| Website | https://www.newamsterdampharma.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
